July 19, 2019 at 1:37 pm

Drug Risks Often Identified After FDA Approval

Sixty two percent of this specific drug class received the FDA’s most stringent warning, known as a “black box.” Most of the serious adverse effects were identified only after the drugs were on the market.
 “It raises the question of should we be regulating them differently,” said Joseph Ross, an associate professor of medicine at Yale School of Medicine, who has studied drug safety. Read the full article here.


July 17, 2019 at 10:18 am

Podcast Series Features MISSD Board Member’s Akathisia Story

Experts by experience is a term increasingly used to describe healthcare consumers and their families who share factual, first-hand experiences relating to pharmaceutical products and doctors’ care.  Gail Regenbogen, a MISSD board member, discusses her late husband, Howard’s, prescribed demise in our second  Akathisia Stories podcast.
Please listen and share so that others can be safer and better informed regarding critical adverse drug effects. Gail eloquently tells her family’s story with profound wisdom acquired after Howard’s akathisia-induced death. Listen here.


July 12, 2019 at 11:55 am

Akathisia Ads Taking Off in Chicago

MISSD is thrilled to reach 500 FB likes today. But even better is that our new Akathisia Awareness ads are taking off on many new Chicago train lines.  Way to roll!

July 9, 2019 at 3:50 am

MISSD Presents Akathisia Info at London Conference

Hundreds of doctors learned more about akathisia during MISSD’s recent presentation at the Royal College of Psychiatrists’ International Congress. Wendy Dolin shared case studies and MISSD videos that highlight the external and internal symptoms doctors should look for when assessing for akathisia.
June 25, 2019 at 9:23 am

MISSD Presents Akathisia Podcast Series

The power of sharing lived experiences is key to creating positive changes in health care. MISSD is pleased to release our first podcast in a series called “Akathisia Stories.” Please listen, learn & share here.


June 24, 2019 at 3:52 pm

Elderly at Risk of Dementia as an Adverse Drug Effect

A recent study published in the JAMA Internal Medicine journal suggests the risk for dementia is strongest for certain classes of anticholinergic drugs — particularly antidepressants, bladder antimuscarinics, antipsychotics and antiepileptic drugs.

For the full article, click here.

June 18, 2019 at 3:41 pm

Drug Safety for Pregnant Women & Nursing Moms

It’s often difficult for pregnant or breastfeeding women to obtain data regarding the safe use of prescription drugs, particularly given it can take more than 20 years to collect reliable safety info on drugs after they come to market. An international effort is underway to improve information in this critical area.

To read the full article, click here.

June 18, 2019 at 1:39 pm

Spring Newsletter

It was a busy Spring for MISSD and we’re excited to share all our good news as well as our plans for a productive summer of programming and development. This includes a 100K grant, a royal presentation in London and a meaningful podcast series of personal stories all should hear.


Check out the link below for more info!

PDF MISSD Newsletter


June 11, 2019 at 1:19 pm

New Warning for Drugs Labeled Antidepressants

Today the European Medicines Agency (EMA) announced it is advising that commonly prescribed drugs called  selective serotonin re-uptake inhibitors (SSRIs) should carry warnings that about the risks of long term sexual dysfunction as an adverse effect. Prozac, Zoloft and Paxil are just a few of many brand-name SSRIs. 

To read the full article, click here.

June 4, 2019 at 2:02 pm

MISSD Discusses Akathisia on K-9’s for Vets Show

The veteran suicide rate is at an all-time high and veterans are increasingly over-medicated. Could akathisia awareness prevent many of these deaths?  Click here to listen.